Symbols / INBS
INBS Chart
About
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 6.64M |
| Enterprise Value | 7.80M | Income | -11.29M | Sales | 3.58M |
| Book/sh | 8.96 | Cash/sh | 0.46 | Dividend Yield | — |
| Payout | 0.00% | Employees | 53 | IPO | — |
| P/E | — | Forward P/E | 11.83 | PEG | — |
| P/S | 1.85 | P/B | 0.46 | P/C | — |
| EV/EBITDA | -0.79 | EV/Sales | 2.18 | Quick Ratio | 2.17 |
| Current Ratio | 2.38 | Debt/Eq | 17.67 | LT Debt/Eq | — |
| EPS (ttm) | -14.45 | EPS next Y | 0.35 | EPS Growth | — |
| Revenue Growth | 47.60% | Earnings | 2024-05-08 08:00 | ROA | -51.17% |
| ROE | -150.20% | ROIC | — | Gross Margin | 46.21% |
| Oper. Margin | -290.89% | Profit Margin | 0.00% | Shs Outstand | 1.60M |
| Shs Float | 1.59M | Short Float | 10.93% | Short Ratio | 0.02 |
| Short Interest | — | 52W High | 25.00 | 52W Low | 3.72 |
| Beta | 4.51 | Avg Volume | 2.45M | Volume | 166.27K |
| Target Price | — | Recom | None | Prev Close | $4.25 |
| Price | $4.14 | Change | -2.59% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
- Construction giant brings drug tests in-house with fingerprint scans at UK sites - Stock Titan ue, 24 Feb 2026 13
- Why Is INBS Stock Rising Today? - Stocktwits Wed, 31 Dec 2025 08
- INBS Stock Surges 132.4% on New Manufacturing Partnership - Yahoo Finance Fri, 02 Jan 2026 08
- Aug Decliners: What are the analyst revisions for Compass IncIs INBS stock a good investment in YEAR - baoquankhu1.vn ue, 24 Feb 2026 18
- Intelligent Bio Solutions Inc. Announces 1-for-10 Reverse Stock Split Effective December 15, 2025 - Quiver Quantitative Fri, 12 Dec 2025 08
- Why Did Intelligent Bio Solutions (INBS) Stock Surge 76% Today? - TipRanks Mon, 05 Jan 2026 08
- Fingerprint drug tests scale up as maker cuts costs by over 40% - Stock Titan Wed, 31 Dec 2025 08
- INBS stock drops today as Intelligent Bio Solutions’ $10M private placement puts dilution in focus - TechStock² Fri, 02 Jan 2026 08
- The Future of Drug Testing? Fingerprint Tech From Intelligent Bio Solutions (NASDAQ:INBS) Shows Serious Promise - simplywall.st Wed, 18 Jun 2025 07
- Intelligent Bio Solutions Completes Strategic $10 Million Financing - The Globe and Mail Sat, 03 Jan 2026 08
- Why Did INBS Stock Fall 17% Today? - Stocktwits Fri, 12 Dec 2025 08
- Intelligent Bio Solutions Inc. Anticipates Record Revenue Growth in Fiscal Q2 2026 Driven by Strong Customer Base Expansion - Quiver Quantitative hu, 05 Feb 2026 08
- INBS Stock May Rise on SMARTOX Partnership Expanding Forensic Reach - Yahoo Finance Mon, 16 Jun 2025 07
- Why Is Intelligent Bio Solutions Stock (INBS) Down Today? - TipRanks Fri, 02 Jan 2026 08
- Intelligent Bio Solutions (Nasdaq: INBS) secures UK deployment with 30,000-staff group - Stock Titan hu, 23 Oct 2025 07
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 34500 | — | — | Stock Award(Grant) at price 0.00 per share. | SAKIRIS SPIRO KEVIN | Chief Financial Officer | — | 2024-09-25 00:00:00 | D |
| 1 | 34500 | nan | — | — | SAKIRIS SPIRO KEVIN | Chief Financial Officer | — | 2024-09-25 00:00:00 | D |
| 2 | 40000 | nan | — | — | SIMEONIDIS HARRY | Chief Executive Officer | — | 2024-09-25 00:00:00 | D |
| 3 | 9394 | nan | — | — | SAKIRIS SPIRO KEVIN | Chief Financial Officer | — | 2024-03-20 00:00:00 | I |
Financials
| Line Item | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -9.11M | -8.99M | -7.46M | -8.32M |
| TotalUnusualItems | -220.97K | 174.56K | -2.01M | -3.99K |
| TotalUnusualItemsExcludingGoodwill | -220.97K | 174.56K | -2.01M | -3.99K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -10.57M | -10.16M | -10.63M | -8.31M |
| ReconciledDepreciation | 1.21M | 1.21M | 966.73K | 0.00 |
| ReconciledCostOfRevenue | 1.80M | 1.67M | 930.20K | 0.00 |
| EBITDA | -9.33M | -8.81M | -9.47M | -8.33M |
| EBIT | -10.54M | -10.02M | -10.44M | -8.33M |
| NetInterestIncome | 40.63K | -82.32K | -213.86K | 6.89K |
| InterestExpense | 60.89K | 167.14K | 223.53K | 7.54K |
| InterestIncome | 101.52K | 84.82K | 9.68K | 14.43K |
| NormalizedIncome | -10.35M | -10.33M | -8.62M | -8.30M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -10.57M | -10.16M | -10.63M | -8.31M |
| TotalExpenses | 13.48M | 13.39M | 9.69M | 8.34M |
| TotalOperatingIncomeAsReported | -10.64M | -10.28M | -12.60M | -8.34M |
| DilutedAverageShares | 527.36K | 159.27K | 8.37K | 6.11K |
| BasicAverageShares | 527.36K | 159.27K | 8.37K | 6.11K |
| DilutedEPS | -20.00 | -63.80 | -1.27K | -1.37K |
| BasicEPS | -20.00 | -63.80 | -1.27K | -1.37K |
| DilutedNIAvailtoComStockholders | -10.57M | -10.16M | -10.63M | -8.31M |
| NetIncomeCommonStockholders | -10.57M | -10.16M | -10.63M | -8.31M |
| NetIncome | -10.57M | -10.16M | -10.63M | -8.31M |
| MinorityInterests | 36.15K | 34.17K | 32.84K | 27.93K |
| NetIncomeIncludingNoncontrollingInterests | -10.60M | -10.19M | -10.66M | -8.33M |
| NetIncomeContinuousOperations | -10.60M | -10.19M | -10.66M | -8.33M |
| TaxProvision | 0.00 | |||
| PretaxIncome | -10.60M | -10.19M | -10.66M | -8.33M |
| OtherIncomeExpense | -220.97K | 174.56K | -2.01M | -3.99K |
| SpecialIncomeCharges | -220.06K | 0.00 | -4.16M | 0.00 |
| ImpairmentOfCapitalAssets | 220.06K | 0.00 | 4.16M | 0.00 |
| EarningsFromEquityInterest | 0.00 | -135.69K | ||
| GainOnSaleOfSecurity | -911.00 | 174.56K | 2.14M | -3.99K |
| NetNonOperatingInterestIncomeExpense | 40.63K | -82.32K | -213.86K | 6.89K |
| InterestExpenseNonOperating | 60.89K | 167.14K | 223.53K | 7.54K |
| InterestIncomeNonOperating | 101.52K | 84.82K | 9.68K | 14.43K |
| OperatingIncome | -10.42M | -10.28M | -8.44M | -8.34M |
| OperatingExpense | 11.67M | 11.71M | 8.76M | 8.34M |
| OtherOperatingExpenses | -816.90K | -424.78K | -737.63K | -437.15K |
| DepreciationAmortizationDepletionIncomeStatement | 1.21M | 1.20M | 966.73K | 0.00 |
| DepreciationAndAmortizationInIncomeStatement | 1.21M | 1.20M | 966.73K | 0.00 |
| ResearchAndDevelopment | 2.40M | 1.67M | 507.42K | 3.85M |
| SellingGeneralAndAdministration | 8.88M | 9.26M | 8.03M | 4.92M |
| GeneralAndAdministrativeExpense | 4.92M | 3.72M | ||
| OtherGandA | 4.92M | 3.72M | ||
| GrossProfit | 1.25M | 1.43M | 326.67K | 0.00 |
| CostOfRevenue | 1.81M | 1.69M | 930.20K | 0.00 |
| TotalRevenue | 3.05M | 3.11M | 1.26M | 0.00 |
| OperatingRevenue | 3.05M | 3.11M | 1.26M | 0.00 |
| Line Item | 2025-06-30 | 2024-06-30 | 2023-06-30 | |
|---|---|---|---|---|
| TreasurySharesNumber | 11.00 | 11.00 | 11.00 | |
| OrdinarySharesNumber | 732.33K | 345.59K | 19.41K | 6.20K |
| ShareIssued | 732.34K | 345.60K | 19.42K | 6.20K |
| TotalDebt | 281.81K | 871.44K | 1.34M | 0.00 |
| TangibleBookValue | -794.18K | 3.96M | -1.46M | 6.62M |
| InvestedCapital | 3.19M | 8.84M | 4.56M | 6.62M |
| WorkingCapital | -1.21M | 3.08M | -2.02M | 6.20M |
| NetTangibleAssets | -794.18K | 3.96M | -1.46M | 6.62M |
| CapitalLeaseObligations | 84.66K | 356.16K | 579.61K | 0.00 |
| CommonStockEquity | 3.00M | 8.33M | 3.80M | 6.62M |
| PreferredStockEquity | 13.00K | |||
| TotalCapitalization | 3.00M | 8.33M | 4.20M | 6.62M |
| TotalEquityGrossMinorityInterest | 2.81M | 8.18M | 3.69M | 6.55M |
| MinorityInterest | -182.31K | -146.16K | -111.99K | -79.15K |
| StockholdersEquity | 3.00M | 8.33M | 3.80M | 6.62M |
| GainsLossesNotAffectingRetainedEarnings | -327.94K | -712.61K | -575.50K | -788.13K |
| OtherEquityAdjustments | -327.94K | -712.61K | -575.50K | -788.13K |
| TreasuryStock | 1.00 | 1.00 | 1.00 | 0.00 |
| RetainedEarnings | -62.53M | -51.96M | -41.81M | -31.18M |
| AdditionalPaidInCapital | 65.78M | 60.97M | 46.18M | 38.58M |
| CapitalStock | 73.23K | 34.56K | 1.94K | 7.45K |
| CommonStock | 73.23K | 34.56K | 1.94K | 7.45K |
| PreferredStock | 0.00 | 0.00 | 13.00K | |
| TotalLiabilitiesNetMinorityInterest | 5.44M | 5.60M | 6.67M | 5.81M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 84.92K | 144.94K | 783.93K | 1.14M |
| EmployeeBenefits | 84.92K | 63.62K | 24.90K | 50.63K |
| NonCurrentDeferredLiabilities | 0.00 | 1.09M | 3.15M | |
| NonCurrentDeferredRevenue | 0.00 | 1.09M | 3.15M | |
| LongTermDebtAndCapitalLeaseObligation | 0.00 | 81.32K | 759.03K | 0.00 |
| LongTermCapitalLeaseObligation | 0.00 | 81.32K | 356.17K | 0.00 |
| LongTermDebt | 402.86K | |||
| CurrentLiabilities | 5.35M | 5.45M | 5.88M | 4.66M |
| OtherCurrentLiabilities | -21.77K | |||
| CurrentDeferredLiabilities | 2.17M | 2.49M | 2.55M | 2.84M |
| CurrentDeferredRevenue | 2.17M | 2.49M | 2.34M | 2.84M |
| CurrentDebtAndCapitalLeaseObligation | 281.81K | 790.12K | 576.66K | |
| CurrentCapitalLeaseObligation | 84.66K | 274.83K | 223.45K | 0.00 |
| CurrentDebt | 197.15K | 515.28K | 353.21K | |
| OtherCurrentBorrowings | 515.28K | 353.21K | ||
| CurrentNotesPayable | 197.15K | 515.28K | ||
| PensionandOtherPostRetirementBenefitPlansCurrent | 534.99K | 469.38K | 358.94K | 201.33K |
| PayablesAndAccruedExpenses | 2.36M | 1.70M | 2.40M | 1.63M |
| CurrentAccruedExpenses | 1.19M | 607.18K | 1.21M | 909.19K |
| Payables | 1.17M | 1.10M | 1.20M | 715.90K |
| DuetoRelatedPartiesCurrent | 190.22K | 444.77K | 0.00 | 13.32K |
| TotalTaxPayable | 84.81K | 50.28K | 0.00 | |
| AccountsPayable | 897.26K | 602.34K | 1.20M | 715.90K |
| TotalAssets | 8.25M | 13.78M | 10.35M | 12.35M |
| TotalNonCurrentAssets | 4.11M | 5.24M | 6.49M | 1.48M |
| OtherNonCurrentAssets | 504.00K | |||
| NonCurrentAccountsReceivable | 1.09M | 3.15M | ||
| GoodwillAndOtherIntangibleAssets | 3.79M | 4.37M | 5.26M | 0.00 |
| OtherIntangibleAssets | 3.79M | 4.37M | 5.26M | |
| NetPPE | 320.85K | 872.59K | 1.24M | 391.41K |
| AccumulatedDepreciation | -88.16K | -60.77K | -33.77K | 0.00 |
| GrossPPE | 409.01K | 933.37K | 1.27M | 391.41K |
| Leases | 21.82K | 20.07K | 20.07K | 0.00 |
| ConstructionInProgress | 0.00 | 543.41K | 646.12K | 391.41K |
| OtherProperties | 151.08K | 369.88K | 604.23K | |
| MachineryFurnitureEquipment | 236.11K | 0.00 | ||
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 4.14M | 8.53M | 3.86M | 10.87M |
| AssetsHeldForSaleCurrent | 327.50K | 0.00 | ||
| CurrentDeferredAssets | 67.16K | 0.00 | 34.10K | 0.00 |
| PrepaidAssets | 489.73K | 474.26K | 478.15K | 163.13K |
| Inventory | 635.22K | 777.54K | 979.91K | 0.00 |
| InventoriesAdjustmentsAllowances | 0.00 | -197.50K | 0.00 | |
| FinishedGoods | 430.13K | 588.84K | 757.52K | 0.00 |
| WorkInProcess | 205.08K | 188.69K | ||
| RawMaterials | 188.69K | 419.89K | 0.00 | |
| Receivables | 1.60M | 978.35K | 833.16K | 2.47M |
| OtherReceivables | 20.00K | 6.30K | 20.13K | 1.56M |
| TaxesReceivable | 984.50K | 542.34K | 519.18K | 410.79K |
| NotesReceivable | 0.00 | 500.44K | 0.00 | |
| AccountsReceivable | 594.61K | 429.70K | 293.86K | 0.00 |
| AllowanceForDoubtfulAccountsReceivable | -546.00 | -6.77K | ||
| GrossAccountsReceivable | 595.16K | 436.48K | ||
| CashCashEquivalentsAndShortTermInvestments | 1.02M | 6.30M | 1.54M | 8.24M |
| CashAndCashEquivalents | 1.02M | 6.30M | 1.54M | 8.24M |
| CashFinancial | 1.02M | 6.30M | 1.54M |
| Line Item | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| FreeCashFlow | -9.91M | -9.79M | -7.88M | -3.74M |
| IssuanceOfCapitalStock | 4.59M | 12.90M | 2.78M | 0.00 |
| CapitalExpenditure | -231.84K | -221.43K | -505.12K | -380.22K |
| InterestPaidSupplementalData | 0.00 | 185.30K | ||
| EndCashPosition | 1.02M | 6.30M | 1.54M | 8.24M |
| BeginningCashPosition | 6.30M | 1.54M | 8.24M | 12.57M |
| EffectOfExchangeRateChanges | 27.16K | -707.00 | -64.86K | -97.13K |
| ChangesInCash | -5.31M | 4.77M | -6.64M | -4.24M |
| FinancingCashFlow | 4.60M | 14.56M | 1.44M | 0.00 |
| CashFlowFromContinuingFinancingActivities | 4.60M | 14.56M | 1.44M | 0.00 |
| NetOtherFinancingCharges | -1.34M | -2.00M | ||
| ProceedsFromStockOptionExercised | 7.94K | 1.66M | 0.00 | 0.00 |
| NetPreferredStockIssuance | 0.00 | 220.58K | 0.00 | 3.29M |
| PreferredStockIssuance | 0.00 | 220.58K | 0.00 | 3.29M |
| NetCommonStockIssuance | 4.59M | 12.90M | 2.55M | 0.00 |
| CommonStockIssuance | 4.59M | 12.90M | 2.55M | 0.00 |
| InvestingCashFlow | -231.84K | -221.43K | -694.14K | -880.22K |
| CashFlowFromContinuingInvestingActivities | -231.84K | -221.43K | -694.14K | -880.22K |
| NetOtherInvestingChanges | -500.00K | |||
| NetInvestmentPurchaseAndSale | 0.00 | -500.00K | ||
| PurchaseOfInvestment | 0.00 | -500.00K | ||
| NetBusinessPurchaseAndSale | 0.00 | -189.02K | 0.00 | |
| SaleOfBusiness | 0.00 | 174.48K | 0.00 | |
| PurchaseOfBusiness | 0.00 | -363.50K | 0.00 | |
| NetPPEPurchaseAndSale | -231.84K | -221.43K | -505.12K | -380.22K |
| PurchaseOfPPE | -231.84K | -221.43K | -505.12K | -380.22K |
| OperatingCashFlow | -9.68M | -9.57M | -7.38M | -3.36M |
| CashFlowFromContinuingOperatingActivities | -9.68M | -9.57M | -7.38M | -3.36M |
| ChangeInWorkingCapital | -720.78K | -701.93K | 78.92K | 2.44M |
| ChangeInOtherWorkingCapital | 21.31K | -364.15K | -66.06K | |
| ChangeInOtherCurrentLiabilities | -271.50K | 51.39K | -133.65K | 28.86K |
| ChangeInOtherCurrentAssets | -329.40K | 55.22K | -118.33K | -333.74K |
| ChangeInPayablesAndAccruedExpense | 2.58M | -632.95K | 84.50K | 242.66K |
| ChangeInPayable | -632.95K | 84.50K | 242.66K | -973.00K |
| ChangeInAccountPayable | -632.95K | 84.50K | 242.66K | -973.00K |
| ChangeInInventory | 142.32K | 202.37K | -345.39K | 0.00 |
| ChangeInReceivables | -2.86M | -13.81K | 591.79K | 2.50M |
| ChangesInAccountReceivables | -164.91K | -135.84K | -293.86K | 0.00 |
| OtherNonCashItems | -24.05K | -24.18K | -222.28K | 2.54M |
| StockBasedCompensation | 238.04K | 230.50K | 260.00K | 0.00 |
| UnrealizedGainLossOnInvestmentSecurities | 0.00 | -175.74K | -2.15M | 0.00 |
| ProvisionandWriteOffofAssets | 546.00 | 6.77K | 189.67K | 0.00 |
| AssetImpairmentCharge | 220.06K | 69.68K | 4.16M | 0.00 |
| DepreciationAmortizationDepletion | 1.21M | 1.21M | 966.73K | 0.00 |
| DepreciationAndAmortization | 1.21M | 1.21M | 966.73K | 0.00 |
| Depreciation | 1.21M | 1.21M | 966.73K | 0.00 |
| OperatingGainsLosses | 1.18K | 9.83K | -3.99K | -135.53K |
| EarningsLossesFromEquityInvestments | 0.00 | 135.69K | ||
| NetForeignCurrencyExchangeGainLoss | 0.00 | 1.18K | 9.83K | -3.99K |
| NetIncomeFromContinuingOperations | -10.60M | -10.19M | -10.66M | -8.33M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for INBS
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|